Stock FPLB FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Fisher & Paykel Healthcare Corporation Limited Börse Stuttgart

Equities

FPLB

NZFAPE0001S2

Medical Equipment, Supplies & Distribution

Delayed Börse Stuttgart
Other stock markets
 02:13:41 2024-05-28 EDT 		5-day change 1st Jan Change
15.3 EUR -1.29% Intraday chart for Fisher & Paykel Healthcare Corporation Limited -1.90% +19.23%
04-09 New Zealand Shares Fall for Second Day; Fisher & Paykel Healthcare Launches Apnea Mask MT
04-09 Fisher & Paykel Begins Selling Lightest Mask for Sleep Apnea MT

Valuation

Fiscal Period: Marzo 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 9,007 17,455 18,494 14,056 15,436 16,153 - -
Enterprise Value (EV) 1 8,953 17,413 18,191 13,835 15,398 16,326 16,382 16,393
P/E ratio 43 x 61.3 x 35.5 x 37.5 x 62 x 62.3 x 48.1 x 39.3 x
Yield 1.48% 0.91% 1.18% 1.62% 1.52% 1.42% 1.56% 1.72%
Capitalization / Revenue 8.41 x 13.8 x 9.38 x 8.36 x 9.76 x 9.32 x 8.3 x 7.44 x
EV / Revenue 8.36 x 13.8 x 9.23 x 8.23 x 9.74 x 9.42 x 8.42 x 7.55 x
EV / EBITDA 26.8 x 40.5 x 23.1 x 23 x 35.7 x 34.8 x 28.3 x 23.9 x
EV / FCF 74.6 x 116 x 41.3 x 74.4 x 572 x 328 x 92.3 x 66.5 x
FCF Yield 1.34% 0.87% 2.42% 1.34% 0.17% 0.3% 1.08% 1.5%
Price to Book 9.85 x 18.1 x 12.2 x 8.37 x 8.8 x 8.95 x 8.5 x 7.92 x
Nbr of stocks (in thousands) 573,709 574,571 576,122 577,269 579,219 583,980 - -
Reference price 2 15.70 30.38 32.10 24.35 26.65 27.66 27.66 27.66
Announcement Date 19-05-26 20-06-28 21-05-26 22-05-24 23-05-25 - - -
1NZD in Million2NZD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Marzo 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,070 1,264 1,971 1,682 1,581 1,733 1,946 2,170
EBITDA 1 334.3 430.2 785.8 601.6 431.2 469.8 579.8 687.1
EBIT 1 292.6 379.3 712.3 505.6 332.2 359.4 459.5 560.5
Operating Margin 27.34% 30.02% 36.14% 30.06% 21.01% 20.74% 23.61% 25.83%
Earnings before Tax (EBT) 1 291.2 370.5 718.2 504.2 328 337.2 444.4 547.1
Net income 1 209.2 287.3 524.2 376.9 250.3 257.7 333.3 404
Net margin 19.54% 22.73% 26.59% 22.41% 15.83% 14.87% 17.13% 18.62%
EPS 2 0.3650 0.4960 0.9040 0.6500 0.4300 0.4439 0.5753 0.7039
Free Cash Flow 1 120 150.7 440.6 185.9 26.9 49.78 177.6 246.6
FCF margin 11.21% 11.93% 22.35% 11.05% 1.7% 2.87% 9.13% 11.37%
FCF Conversion (EBITDA) 35.9% 35.03% 56.07% 30.9% 6.24% 10.59% 30.62% 35.89%
FCF Conversion (Net income) 57.36% 52.45% 84.05% 49.32% 10.75% 19.32% 53.28% 61.04%
Dividend per Share 2 0.2325 0.2750 0.3800 0.3950 0.4050 0.3936 0.4309 0.4751
Announcement Date 19-05-26 20-06-28 21-05-26 22-05-24 23-05-25 - - -
1NZD in Million2NZD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2 2025 S1 2025 S2
Net sales 1 570.9 692.8 910.2 1,061 900 781.7 690.6 890.5 803.7 925.6 905.5 1,053
EBITDA - - - - 348.4 253.2 - 254 - - - -
EBIT 1 166 213.3 309.2 403.1 302.4 203.2 126.7 205.5 152.6 204 191.7 277.2
Operating Margin 29.08% 30.79% 33.97% 37.99% 33.6% 25.99% 18.35% 23.08% 18.99% 22.05% 21.17% 26.33%
Earnings before Tax (EBT) 1 159.7 210.8 313 - 301.1 203.1 114.3 213.7 140.6 194.4 181.2 262
Net income 1 121.2 166.1 225.5 - 221.8 155.1 95.9 154.4 107.3 149.8 139.6 201.8
Net margin 21.23% 23.98% 24.77% - 24.64% 19.84% 13.89% 17.34% 13.35% 16.19% 15.42% 19.17%
EPS 2 0.2090 - 0.3890 0.5150 0.3830 0.2670 0.1660 0.2640 0.1850 0.2580 0.2600 0.3135
Dividend per Share 2 0.1200 0.1550 0.1600 - 0.1700 0.2250 0.1750 0.2250 0.1800 0.2450 0.1900 0.2800
Announcement Date 19-11-26 20-06-28 20-11-24 21-05-26 21-11-24 22-05-24 22-11-28 23-05-25 23-11-28 - - -
1NZD in Million2NZD
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - 174 229 240
Net Cash position 1 54.4 42.2 303 222 37.7 - - -
Leverage (Debt/EBITDA) - - - - - 0.3694 x 0.3945 x 0.3488 x
Free Cash Flow 1 120 151 441 186 26.9 49.8 178 247
ROE (net income / shareholders' equity) 25% 30.5% 42% 23.6% 19.1% 14.5% 17.9% 20.2%
ROA (Net income/ Total Assets) 18.7% 21.8% 29.9% 18% 15.2% 12.3% 14.6% 16.5%
Assets 1 1,116 1,321 1,755 2,091 1,647 2,093 2,289 2,447
Book Value Per Share 2 1.590 1.680 2.640 2.910 3.030 3.090 3.250 3.490
Cash Flow per Share 2 0.4400 0.5600 1.080 0.5600 0.4100 0.6900 0.8300 0.8800
Capex 1 133 171 185 138 188 356 257 232
Capex / Sales 12.45% 13.51% 9.37% 8.23% 11.88% 20.53% 13.19% 10.69%
Announcement Date 19-05-26 20-06-28 21-05-26 22-05-24 23-05-25 - - -
1NZD in Million2NZD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Fisher & Paykel Healthcare Corporation Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
27.66 NZD
Average target price
24.65 NZD
Spread / Average Target
-10.88%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ABBOTT LABORATORIES Stock Abbott Laboratories
-7.71% 181B
MEDTRONIC PLC Stock Medtronic plc
-0.54% 108B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-7.26% 66.12B
DEXCOM, INC. Stock DexCom, Inc.
+2.87% 50.65B
CENCORA, INC. Stock Cencora, Inc.
+5.19% 43.11B
HOYA CORPORATION Stock Hoya Corporation
+3.49% 40.74B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+19.78% 31.6B
TERUMO CORPORATION Stock Terumo Corporation
+16.38% 25.56B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-6.99% 24.16B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. FPH Stock
  4. FPLB Stock
  5. Financials Fisher & Paykel Healthcare Corporation Limited